- Home
- AKAM vs ICLR Comparison
AKAM vs ICLR Comparison
Compare AKAM & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKAM
- ICLR
- Stock Information
- Founded
- AKAM 1998
- ICLR 1990
- Country
- AKAM United States
- ICLR Ireland
- Employees
- AKAM N/A
- ICLR N/A
- Industry
- AKAM Business Services
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- AKAM Consumer Discretionary
- ICLR Health Care
- Exchange
- AKAM Nasdaq
- ICLR Nasdaq
- Market Cap
- AKAM 12.2B
- ICLR 11.4B
- IPO Year
- AKAM 1999
- ICLR 1998
- Fundamental
- Price
- AKAM $78.38
- ICLR $146.48
- Analyst Decision
- AKAM Buy
- ICLR Buy
- Analyst Count
- AKAM 22
- ICLR 12
- Target Price
- AKAM $105.15
- ICLR $204.18
- AVG Volume (30 Days)
- AKAM 2.3M
- ICLR 1.1M
- Earning Date
- AKAM 08-07-2025
- ICLR 07-23-2025
- Dividend Yield
- AKAM N/A
- ICLR N/A
- EPS Growth
- AKAM N/A
- ICLR 11.53
- EPS
- AKAM 2.97
- ICLR 9.19
- Revenue
- AKAM $4,019,337,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- AKAM $5.61
- ICLR N/A
- Revenue Next Year
- AKAM $5.41
- ICLR $2.10
- P/E Ratio
- AKAM $26.20
- ICLR $15.62
- Revenue Growth
- AKAM 3.51
- ICLR N/A
- 52 Week Low
- AKAM $67.51
- ICLR $125.10
- 52 Week High
- AKAM $106.80
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- AKAM 51.57
- ICLR 58.35
- Support Level
- AKAM $76.86
- ICLR $140.20
- Resistance Level
- AKAM $80.03
- ICLR $147.26
- Average True Range (ATR)
- AKAM 1.55
- ICLR 5.06
- MACD
- AKAM 0.24
- ICLR 1.39
- Stochastic Oscillator
- AKAM 69.10
- ICLR 85.25
About AKAM Akamai Technologies Inc.
Akamai operates a content delivery network, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,100 points of presence in more than 1,000 cities worldwide. The firm also offers security and cloud computing for its customers, and those businesses have grown to be bigger than the legacy CDN.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.